Cloudtag Inc (LON:CTAG) CEO Amit Ben-Haim talks to DirectorsTalk about the US deal with CITIES. Amit talks about the commercial strategy for the US launch with CITIES and the impact the US will have for the company.
Amit Ben-Haim has a proven track record as a successful entrepreneur establishing, leading and expanding companies through to trade sale exits as co-founder, executive and non-executive director. In 1993, he co-founded Biosense Inc., a medical devices company which was sold to Dow Jones-listed Johnson & Johnson in 1997 for $485 million. In 1996, he co-established Impulse Dynamics Inc., another medical devices company, which ultimately licensed its cardiac contractility technology to NYSE-listed Guidant Corporation (a group company of Boston Scientific) and in 1998 he was one of several founders of Odigo Inc., a communications company specialising in instant messaging platforms (for example Blackberry’s BBM) which was sold in 2002 to NASDAQ-listed Comverse Inc. Amit’s experience extends across various industries including aviation (private and commercial), infrastructure, corporate finance and wealth management. He has expertise in risk and regulatory compliance for listed companies and is a director of SB Corporate Finance Partners Limited which is authorised by the Financial Conduct Authority to advise on and/or arrange certain investments in the UK.
Cloudtag Inc Track-the most personalized weight loss and fitness wearable. Making real time changes to your journey through machine self-learning and delivered through the app for a truly personal user experience. One track, two modes. On the wrist for daily tracking and your heart, using the beatSMART™ clip, for superior accuracy and reliable results when exercising. You never have to be without your Cloudtag Track™. Smart charge whilst you workout using the beatSMART™ clip.
